Recursion’s Post

View organization page for Recursion, graphic

50,669 followers

“This is a once-in-a-lifetime opportunity.” In a Fireside Chat with Recursion co-founder and CEO Chris Gibson at Download Day, NVIDIA founder and CEO Jensen Huang shared his vision for the future of healthcare, and how the companies are working together on a data-driven approach to drug discovery that has the potential to radically transform medicine.  ◾ Why he’s excited about this collaboration: “If you look at the foundation of Recursion, three things are in play – the invention of a new algorithm, a new family of algorithms that we call deep learning; supercomputing capabilities that you’ve used here and that we’ve partnered with you to create; and the know-how of processing and extracting the meaning of biology that’s embedded within life, within that data.” ◾ With accelerated computing and generative AI, we are changing “the type of problems we can solve,” he added. ◾ NVIDIA has been an incredible partner as we push to develop the next generation of medicines for patients in need -- including their support in building BioHive-2, the largest supercomputer in the pharma industry, which allows us to run more experiments, build more data, and develop even more powerful foundation models. Watch the full Fireside Chat here: https://lnkd.in/evqAm3QB The full day of presentations and slides from Download Day, featuring experts from across the Recursion ecosystem sharing the latest developments on our platform, pipeline and partnerships, is available here: https://lnkd.in/e9bRKvqf  #techbio #future #ai #health #medicine #pharma #tech

Darren Nelson 🚀 (We're hiring)

Innovative Leadership in Life Sciences & Technology Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies

3mo

Wow, what an incredible collaboration! 🌟 It's amazing to see how Recursion and NVIDIA are revolutionizing healthcare through data-driven drug discovery. The development of BioHive-2 and leveraging generative AI are indeed paving the way for groundbreaking advancements in medicine. Exciting times ahead for transforming patient care! 💡💊 hashtag#techbio hashtag#future hashtag#ai hashtag#health hashtag#medicine hashtag#pharma hashtag#tech

Correlating chip designing to biology chemistry life science clinical and pharmaceutical science is insanely novel exciting and next generation. A very bold approach to accelerate science and if this approach becomes successful and follow 1990s-now Nvidia's success story, this could be huge.

David Readerman, CFA

General Partner, Portfolio Manager

3mo

Yes exciting outlook. Then why need to price 31 mn common offering 2 days later down (30%) at $6.50 / share?

Nabeelah Khan

Strategic comms & PR for biotech, healthcare and food industries

3mo

Love this so much - what a beautiful convergence of two visionaries. Y'all are changing the world...for the better. And, I know this is just the beginning!

Simrat Bhandari

Cybersecurity Consultant, Helping Global Clients with Niche Cybersecurity Services || VAPT || Global SOC || SIEM || SOAR || Google Chronicle || Design & Implementation Consultant

2mo

"Exciting to see NVIDIA and Recursion pioneering data-driven drug discovery. Their collaboration promises groundbreaking advancements in healthcare."

Jennifer Sieber

Software Engineer | 100Devs Agency

2mo

I love the energy of this collaboration! I enjoyed the AI with NVIDIA and Recursion at Utah Tech Week earlier this year!

Yuko Hirata

Sr. Medical Director, Medical and Clinical Development, Neurocrine Biosciences

3mo

Great conversation to see how Recursion and NVIDIA change the drug discovery!

See more comments

To view or add a comment, sign in

Explore topics